Newsroom | 27416 results
Sorted by: Latest
-
AOA Statement on HHS Dismissal of USPSTF Vice Chairs
CHICAGO--(BUSINESS WIRE)--Access to evidence-based preventive services is central to delivering whole-person care and supporting long-term patient wellbeing. Representing more than 207,000 osteopathic physicians (DOs) and medical students in the U.S., we are deeply concerned by the abrupt dismissal of the United States Preventive Services Task Force (USPSTF) Vice Chairs and political interference in the USPSTF process. The USPSTF plays a critical role in healthcare coverage and access to servic...
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved treatment for HDV in the United States. The FDA granted accelerated approval to Hepcludex based on reductions in HDV RNA and normalization of alanine aminotrans...
-
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings....
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorization of Trodelvy® (sacituzumab govitecan-hziy) as a monotherapy for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for met...
-
ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced new survey data highlighting the diverse treatment preferences and decision-making priorities of patients with Bacillus Calmette–Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). The findings were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2026, May 17–20, 2026, at the Pennsylvania Conventi...
-
Samenvatting: Carnegie Mellon University en Cleveland Clinic ontwikkelen AI-systeem voor nauwkeurigere interpretatie van MRI-scans van het hart
PITTSBURGH & CLEVELAND--(BUSINESS WIRE)--Een team van onderzoekers van Carnegie Mellon University heeft in samenwerking met het Cardiovascular Innovation Research Center van de Cleveland Clinic een systeem met kunstmatige intelligentie (AI) ontwikkeld dat enkele van de meest complexe hartscans in de geneeskunde, namelijk MRI-scans van het hart, kan interpreteren zonder dat er handmatig gelabelde trainingsgegevens nodig zijn. Het nieuwe systeem, genaamd CMR-CLIP, is ontworpen om MRI-scans van he...
-
Riassunto: Carnegie Mellon University e Cleveland Clinic sviluppano un sistema IA per l'interpretazione delle risonanze magnetiche cardiache con una precisione superiore
PITTSBURGH e CLEVELAND--(BUSINESS WIRE)--Un team di ricercatori della Carnegie Mellon University, in collaborazione con il centro di ricerca per l'innovazione cardiovascolare della Cleveland Clinic, ha sviluppato un sistema di intelligenza artificiale (IA) in grado di interpretare alcuni degli esami cardiaci più complessi in ambito medico, le risonanze magnetiche cardiache, senza la necessità di utilizzare dati di addestramento etichettati manualmente. Il nuovo sistema, chiamato CMR-CLIP, è sta...
-
Carnegie Mellon University und Cleveland Clinic entwickeln KI-System für die präzisere Interpretation von MRT-Aufnahmen des Herzens
PITTSBURGH & CLEVELAND--(BUSINESS WIRE)--Ein Forscherteam der Carnegie Mellon University hat in Zusammenarbeit mit dem Cardiovascular Innovation Research Center der Cleveland Clinic ein System künstlicher Intelligenz (KI) entwickelt, das in der Lage ist, einige der komplexesten medizinischen Aufnahmen des Herzens, kardiale Magnetresonanztomographie (MRT), zu interpretieren, ohne dass manuell gekennzeichnete Trainingsdaten erforderlich wären. Das neue System CMR-CLIP interpretiert MRT-Aufnahmen...
-
L'université Carnegie Mellon et la Cleveland Clinic développent un système d'IA dédié à une interprétation encore plus précise des IRM cardiaques
PITTSBURGH et CLEVELAND--(BUSINESS WIRE)--Une équipe de chercheurs de l'université Carnegie Mellon , en collaboration avec le le Centre de recherche sur l'innovation cardiovasculaire de la Cleveland Clinic, a développé un système d'intelligence artificielle (IA) capable d'interpréter certains des examens cardiaques les plus complexes en médecine, comme l'imagerie par résonance magnétique (IRM) cardiaque, sans nécessiter de données d'apprentissage étiquetées manuellement. Ce nouveau système, bap...
-
Resumen: La Universidad Carnegie Mellon y la Cleveland Clinic desarrollan un sistema de IA para interpretar con mayor precisión resonancias magnéticas cardíacas
PITTSBURGH y CLEVELAND--(BUSINESS WIRE)--Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con el Centro de Investigación de Innovación Cardiovascular de la Cleveland Clinic, ha desarrollado un sistema de inteligencia artificial (IA) capaz de interpretar una de las exploraciones del corazón más complejas en medicina, las imágenes por resonancia magnética (IRM) cardíacas, sin necesidad de datos de entrenamiento etiquetados manualmente. El nuevo sistema, llamado CMR-C...
